BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alavi SE, Ebrahimi Shahmabadi H. Anthelmintics for drug repurposing: Opportunities and challenges. Saudi Pharm J 2021;29:434-45. [PMID: 34135669 DOI: 10.1016/j.jsps.2021.04.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Meco D, Attinà G, Mastrangelo S, Navarra P, Ruggiero A. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers. Int J Mol Sci 2023;24. [PMID: 36674870 DOI: 10.3390/ijms24021334] [Reference Citation Analysis]
2 Choi HS, Ko YS, Jin H, Kang KM, Ha IB, Jeong H, Lee JH, Jeong BK, Kim HJ. Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity. Int J Mol Sci 2022;23. [PMID: 36555137 DOI: 10.3390/ijms232415493] [Reference Citation Analysis]
3 Alavi SE, Panah N, Page F, Gholami M, Dastfal A, Sharma LA, Ebrahimi Shahmabadi H. Hydrogel-based therapeutic coatings for dental implants. European Polymer Journal 2022;181:111652. [DOI: 10.1016/j.eurpolymj.2022.111652] [Reference Citation Analysis]
4 Alavi SE, Raza A, Koohi Moftakhari Esfahani M, Akbarzadeh A, Abdollahi SH, Ebrahimi Shahmabadi H. Carboplatin Niosomal Nanoplatform for Potentiated Chemotherapy. J Pharm Sci 2022;111:3029-37. [PMID: 35675875 DOI: 10.1016/j.xphs.2022.06.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Alavi SE, Raza A, Gholami M, Giles M, Al-sammak R, Ibrahim A, Ebrahimi Shahmabadi H, Sharma LA. Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens. Pharmaceutics 2022;14:2293. [DOI: 10.3390/pharmaceutics14112293] [Reference Citation Analysis]
6 Ghaferi M, Raza A, Koohi M, Zahra W, Akbarzadeh A, Ebrahimi Shahmabadi H, Alavi SE. Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma. Pharmaceutics 2022;14:2183. [DOI: 10.3390/pharmaceutics14102183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Basha NJ. Therapeutic Efficacy of Benzimidazole and Its Analogs: An Update. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2118334] [Reference Citation Analysis]
8 Alavi SE, Bakht U, Koohi Moftakhari Esfahani M, Adelnia H, Abdollahi SH, Ebrahimi Shahmabadi H, Raza A. A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics. Pharmaceutics 2022;14:1668. [DOI: 10.3390/pharmaceutics14081668] [Reference Citation Analysis]
9 Beld L, Jung H, Bulman CA, Rosa BA, Fischer PU, Janetka JW, Lustigman S, Sakanari JA, Mitreva M. Aspartyl Protease Inhibitors as Anti-Filarial Drugs. Pathogens 2022;11:707. [PMID: 35745561 DOI: 10.3390/pathogens11060707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Koohi Moftakhari Esfahani M, Alavi SE, Cabot PJ, Islam N, Izake EL. β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Pharmaceutics 2022;14:884. [PMID: 35456716 DOI: 10.3390/pharmaceutics14040884] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Ghaferi M, Zahra W, Akbarzadeh A, Ebrahimi Shahmabadi H, Alavi SE. Enhancing the efficacy of albendazole for liver cancer treatment using mesoporous silica nanoparticles: an in vitro study. EXCLI J 2022;21:236-49. [PMID: 35221842 DOI: 10.17179/excli2021-4491] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Alavi SE, Esfahani MKM, Raza A, Adelnia H, Shahmabadi HE. PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: An in vivo study. NanoImpact 2022. [DOI: 10.1016/j.impact.2022.100384] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
13 Hajnal K, Edina MP, Adrienn R, Lajos-attila P. Chemical and pharmacological characterization of anthelmintic benzimidazoles. Bulletin of Medical Sciences 2021;94:88-96. [DOI: 10.2478/orvtudert-2021-0013] [Reference Citation Analysis]
14 Esfahani MKM, Alavi SE, Cabot PJ, Islam N, Izake EL. PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells. Pharmaceutics 2021;13:1605. [PMID: 34683898 DOI: 10.3390/pharmaceutics13101605] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
15 Oripov A, Scientific Research Institute of Veterinary Medicine of the Republic of Uzbekistan, Yuldashev N, State Committee for Veterinary Medicine and Livestock Development of the Republic of Uzbekistan. MODERN STRATEGY, NEW METHODS AND MEANS FOR CONTROL OF HELMINTHIASES IN UZBEKISTAN. Ukrainian journal of veterinary sciences 2021;12. [DOI: 10.31548/ujvs2021.03.007] [Reference Citation Analysis]
16 Esfahani MKM, Islam N, Cabot PJ, Izake EL. Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy. ACS Biomater Sci Eng 2021. [PMID: 34056895 DOI: 10.1021/acsbiomaterials.1c00066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]